285 related articles for article (PubMed ID: 17330820)
21. Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4.
Iizuka A; Ikarashi Y; Yoshida M; Heike Y; Takeda K; Quinn G; Wakasugi H; Kitagawa M; Takaue Y
Immunology; 2008 Jan; 123(1):100-7. PubMed ID: 18005033
[TBL] [Abstract][Full Text] [Related]
22. Expression of Th1/Th2 cytokine mRNA in peritoneal exudative polymorphonuclear neutrophils and their effects on mononuclear cell Th1/Th2 cytokine production in MRL-lpr/lpr mice.
Yu C; Sun K; Tsai C; Tsai Y; Tsai S; Huang D; Han S; Yu H
Immunology; 1998 Nov; 95(3):480-7. PubMed ID: 9824514
[TBL] [Abstract][Full Text] [Related]
23. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
Müller A; Schott-Ohly P; Dohle C; Gleichmann H
Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
[TBL] [Abstract][Full Text] [Related]
25. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.
Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T
Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285
[TBL] [Abstract][Full Text] [Related]
26. Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock.
Sireci G; La Manna MP; Di Sano C; Di Liberto D; Porcelli SA; Kronenberg M; Dieli F; Salerno A
J Leukoc Biol; 2007 Mar; 81(3):607-22. PubMed ID: 17046969
[TBL] [Abstract][Full Text] [Related]
27. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
[TBL] [Abstract][Full Text] [Related]
28. IFN-gamma production from liver mononuclear cells of mice in burn injury as well as in postburn bacterial infection models and the therapeutic effect of IL-18.
Ami K; Kinoshita M; Yamauchi A; Nishikage T; Habu Y; Shinomiya N; Iwai T; Hiraide H; Seki S
J Immunol; 2002 Oct; 169(8):4437-42. PubMed ID: 12370378
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Th1/Th2 ratio and cytokine production profile during acute exacerbation and convalescence in asthmatic children.
Kuo ML; Huang JL; Yeh KW; Li PS; Hsieh KH
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):272-6. PubMed ID: 11289323
[TBL] [Abstract][Full Text] [Related]
30. The liquid culture filtrates of Paecilomyces tenuipes (Peck) Samson (=Isaria japonica Yasuda) and Paecilomyces cicadae (Miquel) Samson (=Isaria sinclairii (Berk.) Llond) regulate Th1 and Th2 cytokine response in murine Peyer's patch cells in vitro and ex vivo.
Takano F; Yahagi N; Yahagi R; Takada S; Yamaguchi M; Shoda S; Murase T; Fushiya S; Ohta T
Int Immunopharmacol; 2005 May; 5(5):903-16. PubMed ID: 15778126
[TBL] [Abstract][Full Text] [Related]
31. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
Akarid K; Pocidalo MA; Desforges B; Sinet M
Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
[TBL] [Abstract][Full Text] [Related]
34. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines.
Wallace FA; Miles EA; Evans C; Stock TE; Yaqoob P; Calder PC
J Leukoc Biol; 2001 Mar; 69(3):449-57. PubMed ID: 11261793
[TBL] [Abstract][Full Text] [Related]
35. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
36. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
[TBL] [Abstract][Full Text] [Related]
37. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.
Schmieg J; Yang G; Franck RW; Tsuji M
J Exp Med; 2003 Dec; 198(11):1631-41. PubMed ID: 14657217
[TBL] [Abstract][Full Text] [Related]
38. Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NKT cells and antigen-presenting cells.
Yang YF; Tomura M; Ono S; Hamaoka T; Fujiwara H
Int Immunol; 2000 Dec; 12(12):1669-75. PubMed ID: 11099306
[TBL] [Abstract][Full Text] [Related]
39. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L
J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969
[TBL] [Abstract][Full Text] [Related]
40. OCH-mediated shift of Th1 and Th2 cytokines by NKT cells in mice with aplastic anemia.
Qiao X; Xie X; Shi W; Tang J; Shao Y; Li F
Med Oncol; 2015 Mar; 32(3):67. PubMed ID: 25691295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
